Urinary Incontinence: Major Milestones - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/296320

Urinary Incontinence: Major Milestones

Description:

Urinary incontinence has three main subtypes including stress, urge and mixed, and is estimated to affect 100 million women in the seven major markets. Drug therapy for urinary incontinence has focused on overactive bladder, worth over $1.3 billion in 2003. Lilly/BI's Yentreve, launched in 2004, is the first drug treatment for stress incontinence, the most prevalent subtype of the condition.

Report Scope

- In-depth primary research interviews with key opinion leaders from the US and Europe to add insight on market developments and unmet needs
- Analysis of recent market events including new drug launches and impact on the market
- Secondary resources include IMS MIDAS sales and promotional data across the seven major markets, IDdb, IMS R&D Focus, Medline

Report Highlights

Despite the high prevalence of urinary incontinence among women, few are diagnosed and treated due to a number of barriers preventing help-seeking behavior. There is a need to greater disease education among patients to lessen embarrassment about the condition and raise awareness of effective treatments.

The UI market was worth $1.3 billion in 2003 with sales dominated by leading overactive bladder drugs including Detrol (Pfizer) and oxybutynin in its various forms. New drug launches in OAB Vesicare (Yamanouchi) and Enablex (Novartis) could usurp Pfizer's dominance, while Yentreve will open up a new and underserved segment and driving growth.

Opinion leaders have identified a number of unmet needs in the urinary incontinence market, particularly the need for greater support for health professionals in terms of differentiating, diagnosing and treating UI subtypes in the long term and the need for greater disease awareness both among patients and physicians.

Why you should buy this report

1. Understand barriers to treatment in the female UI population including obstacles in help-seeking behavior and difficulties in the diagnostic pathway

2. Identify physicians key concerns in urinary incontinence including unmet needs and desirable attributes of novel drugs for Overactive Bladder

3. Evaluate new drugs entering the market including key efficacy and safety trial data and their potential impact on the market

This product has been designed for delivery in a slide pack format (ppt).

Contents:

Overview of Urinary Incontinence from the following perspectives:

-epidemiology
-etiology
-definitions and subtypes
-therapeutic strategies
-pipeline products
-unmet needs
-impact of recent market events including first global launch of marketed product for stress incontinence

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/296320

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 27/11/2009 07:35:21

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
Urinary Incontinence: Major Milestones
Web Address:
http://www.researchandmarkets.com/reports/296320
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic		€3,358.00

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 27/11/2009 07:35:21

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)